<DOC>
	<DOC>NCT01306773</DOC>
	<brief_summary>Treatment of severe 2009 H1N1 infection with convalescent plasma will reduce mortality.</brief_summary>
	<brief_title>Convalescent Plasma Treatment in Severe 2009 H1N1 Infection</brief_title>
	<detailed_description>Patients presented with severe 2009 H1N1 infection responded poorly to antiviral agents. Meta-analysis of reports from 1918 H1N1 pandemic suggested that convalescent plasma might be an effective treatment option for patients with severe 2009 H1N1 infection.</detailed_description>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>adult patients â‰¥ 18 years old with written informed consent given by patient or nextofkin laboratory confirmatory diagnosis of 2009 H1N1 infection by positive RTPCR from respiratory specimens required intensive care within 7 days of onset of symptoms age 18 years old or below known hypersensitivity to immune globulin known IgA deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Influenza A</keyword>
	<keyword>convalescent plasma</keyword>
	<keyword>death</keyword>
</DOC>